Fitness

ads
Sodium Iodide I-123 Capsules for Oral Administration

Sodium Iodide I-123 Capsules for Oral Administration

Amersham Health

Sodium Iodide I-123 Capsules for Oral Administration

Manufacturer MSDS Number:

MSDS Name: Sodium Iodide I-123 Capsules for Oral Administration
Manufacturer Name:Amersham Health
Address:
3350 North Ridge Avenue
Arlington Heights, IL 60004



Business Phone:(847) 398-8400
For information in North America, call: (847) 398-8400
Manufacturer MSDS Revision Date:
April 2003
CAS Number: Not applicable to mixtures.
Chemical Formula: Na123I
Molecular Weight: 146
Product Codes:
2031, 2032
(mm Hg): Not applicable.
(Air=1): Not applicable.
Dissolves in water.
Concentration: Approximately 91µCi/g.

Half-Life: 13.2 hrs.

Radioactivity:
100 µCi/capsule at time of calibration;
200 µCi/capsule at time of calibration.

Specific Activity: 213 µCi/mg of I-123 at time of calibration.
Substance is non-flammable.
Not considered an explosion hazard.
Use water spray, dry chemical, Co2 or foam as appropriate for the burning material.
Special Information: In the event of a fire, wear full protective clothing and a NIOSH approved self-contained breathing apparatus.
Thermal decomposition may release radioactive Iodine.
Radioactive Iodine:
Potential Health Effects:
Eye Contact:
Effects of Overexposure:
May cause mechanical irritation.
Skin Contact:
Effects of Overexposure:
Not considered an acute health hazard.
Inhalation:
Effects of Overexposure:
May cause asymptomatic uptake by thyroid gland.
Ingestion:
Effects of Overexposure:
May cause asymptomatic uptake by thyroid gland.
Chronic Health Effects:
Effects of Overexposure:
Data on biological effects of Ionizing Radiation are based on exposures much higher than those permitted occupationally. No effects are expected from exposures received as a result of normal use.
Aggravation of Pre-Existing Conditions:
May cause allergic reaction in individuals sensitive to iodine.
Scientific studies have indicated that large exposures to ionizing radiation can result in an increased probability of longterm biological effects such as cancer and birth defects. Although these effects have been difficult to demonstrate at low levels of exposure, efforts should be made to keep exposures as low as reasonably achievable.
Wash thoroughly with soap and water or other approved decontamination media. Notify Radiation Safety Officer.
Radiopharmaceuticals must be handled with care and appropriate safety measures should be used to minimize exposure to personnel. Radiopharmaceuticals should be used only by physicians who are qualified by training and experience in safe use and handling of radionuclides, and where experience and training have been approved by the appropriate regulatory agency authorized to license the use of radionuclides.
SPECIAL PRECAUTIONS:
Any cleanup of spilled radioactive material should be conducted under the direction of site radiation safety personnel. Any packages received with leaking internal components should be reported to Amersham Health Technical Services at 1-800-832-4633. Any packages delivered in a damaged condition should be reported to Amersham Health Environmental Regulatory Affairs at 847-398-8400.
Precautions: Practice good housekeeping and personal hygiene to preclude the possibility of contaminating work surfaces, equipment and skin. Avoid inhaling dust or mist; do not pipette solutions by mouth. No smoking, eating, or drinking where radioactive materials are handled or stored.
CALIFORNIA PROPOSITION 65 INFORMATION:
The State of California requires that customers and employees are provided with warnings about reproductive and carcinogenic hazards associated with substances sold in California. Radioactive materials are suspected to cause reproductive toxicity. Under Proposition 65, the following warning applies:
WARNING: This product contains a substance known to the State of California to cause reproductive toxicity.
MSDS Revision Date:
April 2003
Disclaimer:
MATERIAL SAFETY DATA SHEET STANDARD FORM DISCLAIMER:
The above information is based upon data available to Amersham Health and is believed to be correct, but does not intend to be all inclusive and shall be used only as a guide. Since the information contained herein may be applied under conditions beyond the control of Amersham Health, no responsibility is assumed for the results of its use.

Copyright© 1996-2005 Actio Software Corporation. All Rights Reserved.
ads